- Home
- MCRB vs NRGV Comparison
MCRB vs NRGV Comparison
Compare MCRB & NRGV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MCRB
- NRGV
- Stock Information
- Founded
- MCRB 2010
- NRGV 2017
- Country
- MCRB United States
- NRGV United States
- Employees
- MCRB N/A
- NRGV N/A
- Industry
- MCRB Biotechnology: Pharmaceutical Preparations
- NRGV Industrial Machinery/Components
- Sector
- MCRB Health Care
- NRGV Miscellaneous
- Exchange
- MCRB Nasdaq
- NRGV Nasdaq
- Market Cap
- MCRB 103.7M
- NRGV 102.3M
- IPO Year
- MCRB 2015
- NRGV N/A
- Fundamental
- Price
- MCRB $12.09
- NRGV $0.84
- Analyst Decision
- MCRB Hold
- NRGV Buy
- Analyst Count
- MCRB 4
- NRGV 3
- Target Price
- MCRB $73.67
- NRGV $1.58
- AVG Volume (30 Days)
- MCRB 107.4K
- NRGV 1.9M
- Earning Date
- MCRB 08-12-2025
- NRGV 08-05-2025
- Dividend Yield
- MCRB N/A
- NRGV N/A
- EPS Growth
- MCRB N/A
- NRGV N/A
- EPS
- MCRB 8.98
- NRGV N/A
- Revenue
- MCRB N/A
- NRGV $46,974,000.00
- Revenue This Year
- MCRB N/A
- NRGV $362.17
- Revenue Next Year
- MCRB N/A
- NRGV $48.19
- P/E Ratio
- MCRB $1.42
- NRGV N/A
- Revenue Growth
- MCRB N/A
- NRGV N/A
- 52 Week Low
- MCRB $6.53
- NRGV $0.60
- 52 Week High
- MCRB $30.60
- NRGV $2.70
- Technical
- Relative Strength Index (RSI)
- MCRB 66.74
- NRGV 50.54
- Support Level
- MCRB $10.67
- NRGV $0.81
- Resistance Level
- MCRB $12.84
- NRGV $0.89
- Average True Range (ATR)
- MCRB 1.09
- NRGV 0.07
- MACD
- MCRB 0.34
- NRGV 0.01
- Stochastic Oscillator
- MCRB 85.98
- NRGV 77.12
About MCRB Seres Therapeutics Inc.
Seres Therapeutics Inc is a microbiome therapeutics platform company operating in the United States. The company is engaged in developing biological drugs which are referred as ecobiotic microbiome therapeutics. The drugs discovered by the company are designed to restore health by repairing the function of a dysbiotic microbiome. The company focuses on implementing its microbiome therapeutics platform to develop ecobiotic microbiome therapeutics that treat dysbiosis in the colonic microbiome. SER-109, the company's product, is designed to prevent further recurrences of Clostridium difficile infection (CDI), a debilitating infection of the colon. In addition, the company is involved in developing SER-262, SER-287, and SER-401.
About NRGV Energy Vault Holdings Inc.
Energy Vault Holdings Inc is a grid-scale energy storage company that is driving a faster transition to renewable power by solving the intermittence issues that are inherent to the prevalent sources of renewable energy, solar and wind. Geographical presence in United States, China and Other. Majority of its revenue comes from U.S.